Your browser doesn't support javascript.
loading
Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer.
Tezuka, Kenji; Takashima, Tsutomu; Kashiwagi, Shinichiro; Kawajiri, Hidemi; Tokunaga, Shinya; Tei, Seika; Nishimura, Shigehiko; Yamagata, Shigehito; Noda, Satoru; Nishimori, Takeo; Mizuyama, Yoko; Sunami, Takeshi; Ikeda, Katsumi; Ogawa, Yoshinari; Onoda, Naoyoshi; Ishikawa, Tetsuro; Kudoh, Shinzoh; Takada, Minoru; Hirakawa, Kosei.
Afiliación
  • Tezuka K; Department of Breast Surgery, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Osaka 591-8555, Japan.
  • Takashima T; Department of Surgical Oncology, Osaka University Graduate School of Medicine, Osaka 545-8585, Japan.
  • Kashiwagi S; Department of Surgical Oncology, Osaka University Graduate School of Medicine, Osaka 545-8585, Japan.
  • Kawajiri H; Department of Head, Neck and Breast Surgery, Ishikiriseiki Hospital, Higashiosaka, Osaka 579-8026, Japan.
  • Tokunaga S; Department of Clinical Oncology, Osaka General Hospital, Osaka 534-0021, Japan.
  • Tei S; Department of Surgery, Seichokai Fuchu Hospital, Izumi, Osaka 594-0076, Japan.
  • Nishimura S; Department of Surgery, Sumitomo Hospital, Osaka 530-0005, Japan.
  • Yamagata S; Department of Surgery, Sumitomo Hospital, Osaka 530-0005, Japan.
  • Noda S; Department of Surgical Oncology, Osaka University Graduate School of Medicine, Osaka 545-8585, Japan.
  • Nishimori T; Department of Surgery, Ikuwakai Memorial Hospital, Osaka 544-0004, Japan.
  • Mizuyama Y; Department of Surgery, Ohno Memorial Hospital, Osaka, Osaka 550-0015, Japan.
  • Sunami T; Department of Surgery, Izumi Municipal Hospital, Izumi, Osaka 594-0071, Japan.
  • Ikeda K; Department of Breast Surgery, Osaka General Hospital, Osaka 534-0021, Japan.
  • Ogawa Y; Department of Breast Surgery, Osaka General Hospital, Osaka 534-0021, Japan.
  • Onoda N; Department of Surgical Oncology, Osaka University Graduate School of Medicine, Osaka 545-8585, Japan.
  • Ishikawa T; Department of Surgery, Kashiwara Municipal Hospital, Kashiwara, Osaka 582-0005, Japan.
  • Kudoh S; Department of Internal Medicine, Osaka Socio-Medical Center Hospital, Osaka 557-0004, Japan.
  • Takada M; Hanwa Daini Senboku Hospital, Sakai, Osaka 599-8271, Japan.
  • Hirakawa K; Department of Surgical Oncology, Osaka University Graduate School of Medicine, Osaka 545-8585, Japan.
Mol Clin Oncol ; 6(4): 534-538, 2017 Apr.
Article en En | MEDLINE | ID: mdl-28413662
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Clin Oncol Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Clin Oncol Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido